Insiders · Profile

Young Jeffrey E

Chief Financial Officer at Tempest Therapeutics. Filing since 8 Apr 2015. CIK 0001367556

Company
Date
Role
Action
Shares
Amount
Of holding
5 Oct 2015
Chief Financial Officer
Bought
3,450
$36.92K
×12
8 Apr 2015
Chief Financial Officer
Bought
300
$8.98K
opened
2 decisions on file.